Seventeen years of statin pharmacogenetics: a systematic review
M Leusink, NC Onland-Moret, PIW de Bakker… - …, 2016 - Taylor & Francis
Aim: We evaluated the evidence of pharmacogenetic associations with statins in a
systematic review. Methods: Two separate outcomes were considered of interest …
systematic review. Methods: Two separate outcomes were considered of interest …
Seventeen years of statin pharmacogenetics: a systematic review
M Leusink, NC Onland-Moret… - …, 2016 - search.proquest.com
Aim: We evaluated the evidence of pharmacogenetic associations with statins in a
systematic review. Methods: Two separate outcomes were considered of interest …
systematic review. Methods: Two separate outcomes were considered of interest …
Seventeen years of statin pharmacogenetics: a systematic review.
M Leusink, NC Onland-Moret, PI de Bakker… - …, 2015 - europepmc.org
Methods Two separate outcomes were considered of interest: modification of low-density
lipoprotein cholesterol (LDL-C) response and modification of risk for cardiovascular events …
lipoprotein cholesterol (LDL-C) response and modification of risk for cardiovascular events …
Seventeen years of statin pharmacogenetics: a systematic review
M Leusink, NC Onland-Moret… - …, 2016 - researchinformation.amsterdamumc …
Aim: We evaluated the evidence of pharmacogenetic associations with statins in a
systematic review. Methods: Two separate outcomes were considered of interest …
systematic review. Methods: Two separate outcomes were considered of interest …
Seventeen years of statin pharmacogenetics: a systematic review
M Leusink, NC Onland-Moret… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Aim We evaluated the evidence of pharmacogenetic associations with statins in a systematic
review. Methods Two separate outcomes were considered of interest: modification of low …
review. Methods Two separate outcomes were considered of interest: modification of low …